Toggle Navigation

Apply
Contact

Research
Back
Research at Vienna BioCenter
Research Entities
Research Areas Research Areas Open Submenu
Back
Back to Research Areas
Anthropogenic Evolution
Biochemistry, Biophysics, Structure
Cell and Chromosome Biology
Cognitive and Behavioral Biology
Computational Biology, Genomes and Evolution
Disease Mechanisms, Immunology, Pathogens
Gene Regulation, RNA, Epigenetics
Microbiology and Environmental Systems Science
Neurobiology
Plant Sciences
Stem Cells, Development, Regeneration
Research Groups
Key Discoveries Key Discoveries Open Submenu
Back
Back to Key Discoveries
CRISPR/Cas9
MECHANISMS OF CHROMOSOME SEGREGATION
HUMAN BRAIN ORGANOIDS
EPIGENETICS
1001 GENOMES
Recent Research Highlights
VBCF
Back
Companies
Back
Companies at Vienna BioCenter
Biotech Companies Biotech Companies Open Submenu
Back
Back to Biotech Companies
a:head
Ablevia Biotech
ACCANIS Biotech
ADvantage Therapeutics
Affiris CVD GmbH
aitiologic GmbH
Akribes
Austrianni
BioNTech R&D Austria
Biosynth
Bird-C
bit.bio discovery GmbH
CALYXHA Biotechnologies
ChanPharm
Eveliqure
Evercyte
Exscientia
G.ST Antivirals
HD Immune
HeartBeat.bio AG
HOOKIPA Pharma Inc.
invIOs
JLP Health
Lexogen
Miti Biosystems
MyeloPro Diagnostics and Research GmbH
Myllia Biotechnology
OncoOne
Pregenerate
proxygen GmbH
QUANTRO Therapeutics
SCARLETRED
TAmiRNA
Thermo Fisher Scientific
THT Biomaterials GmbH
Tridem Bioscience
Valneva
X4 Pharmaceuticals
YGION Biomedical GmbH
Service Companies Service Companies Open Submenu
Back
Back to Service Companies
Biolution
LabConsulting
net4biz
IG StartUP Solutions GmbH
Business Incubators Business Incubators Open Submenu
Back
Back to Business Incubators
CEBINA
INiTS
Education
Career
Back
Open Positions
Why Work Here Why Work Here Open Submenu
Back
Back to Why Work Here
Campus Life
Life in Vienna
About
Back
About Vienna BioCenter
VBC at a Glance VBC at a Glance Open Submenu
Back
Back to VBC at a Glance
Who is Here (Members)
History
Management Team
Virtual Tour
Events at the Vienna BioCenter
News (current)
Sustainability
Downloads
Contact

Search

VBC
About
News
Valneva Initiates Phase 3 Clinical Lot Consistency Study for its Single-Shot Chikungunya Vaccine Candidate

Valneva Initiates Phase 3 Clinical Lot Consistency Study for its Single-Shot Chikungunya Vaccine Candidate

22 Feb'21

Valneva announced that it has initiated the clinical lot-to-lot consistency Phase 3 study for its single-shot chikungunya vaccine candidate, VLA1553.

Top

News
Research Groups
Events
Biotech Companies
Downloads
Job Offers
Cafeteria Menu
Contact

Vienna BioCenter
Campus-Vienna-Biocenter 1
1030 Vienna
Austria

© Vienna BioCenter

Legal Notice & Imprint

Cookies

The website uses cookies to ensure you get the best experience on our website.

Learn More

Analysis / statistics

( 1 Service )

Anonymous evaluation for troubleshooting and further development

no Analysis / statistics ( 1 Service )

yes

Google Ireland Limited

no Google Ireland Limited

yes

Google Ireland Limited Show details Hide details

Purpose: error analysis, statistical evaluation of our website accesses, campaign analysis, conversion tracking, retargeting
Processing operations: Collection of access data, data from your browser and data about the content accessed; Execution of analysis software and storage of data on your terminal device, anonymization of the data collected; Evaluation of the anonymous data in the form of statistics
Storage period: data on your device for up to two years.
Joint controller: Google Ireland Limited, Gordon House, Barrow Street, Dublin 4, Ireland Legal basis for data processing: voluntary, consent that can be revoked at any time Consequences of non-consent: No direct impact on the functionality of the website; however limited opportunities for further development and error analysis
Data transfer to the USA: Your data is processed by the provider Google in the USA, which involves corresponding risks, e.g. B. a secret data access by US authorities. With your consent, you also consent to the processing of your data in the USA.